Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Tripelennamine Hydrochloride Patent Expiration

Tripelennamine Hydrochloride was first introduced by Novartis Pharmaceuticals Corp in its drug Pbz on Approved Prior to Jan 1, 1982. Another drug containing Tripelennamine Hydrochloride is Pbz-Sr. 9 different companies have introduced drugs containing Tripelennamine Hydrochloride.


About Veterinary Tripelennamine Hydrochloride

Tripelennamine Hydrochloride is used in drugs marketed by 2 different companies: Huvepharma Eood, Kinetic Technologies Llc.

Other drugs containing Tripelennamine Hydrochloride are: Tripelennamine hydrochloride injection , Re covr .

Tripelennamine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tripelennamine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Tripelennamine Hydrochloride. The first generic version for Tripelennamine Hydrochloride was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Nylos Trading Co Inc and was approved on Approved Prior to Jan 1, 1982.

Given below is the list of companies who have filed for Tripelennamine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.